Clinical Trials
14
Active:0
Completed:13
Trial Phases
1 Phases
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
4 (100.0%)What Lies Beneath the Stone? Metabolic Insights From Composition-Based Analysis of Kidney Stones
Completed
- Conditions
- Urolithiasis, Calcium Oxalate
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Hisar Intercontinental Hospital
- Target Recruit Count
- 506
- Registration Number
- NCT06992206
The Role of Preoperative Ureteral Diameter Measurements in Predicting Difficult Access During Retrograde Intrarenal Surgery: A Retrospective Analysis of 234 Patients
Completed
- Conditions
- Kidney StonesRetrograde Intrarenal SurgeryDifficult Ureteral Access Prediction
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Hisar Intercontinental Hospital
- Target Recruit Count
- 234
- Registration Number
- NCT06746779
- Locations
- πΉπ·
Basri Cakiroglu, Istanbul, Turkey
πΉπ·Hisar Intercontinental Hospital, Istanbul, Turkey
Effect of PECS II, Parasternal and Serratus Plane Blocks on Postoperative Pain in MIDCAB Surgery
Not Applicable
Not yet recruiting
- Conditions
- Pain, PostoperativeCoronary Artery Disease
- First Posted Date
- 2024-09-05
- Last Posted Date
- 2024-09-05
- Lead Sponsor
- Hisar Intercontinental Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06584981
Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases
Completed
- Conditions
- Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases
- First Posted Date
- 2024-06-14
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Hisar Intercontinental Hospital
- Target Recruit Count
- 151
- Registration Number
- NCT06459713
- Locations
- πΉπ·
Hisar Intercontinental Hospital, Istanbul, Turkey
Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment
Completed
- Conditions
- Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment
- First Posted Date
- 2024-05-09
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Hisar Intercontinental Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06408051
- Locations
- πΉπ·
Basri Cakiroglu, Istanbul, Turkey
πΉπ·Hisar Intercontinental Hospital, Istanbul, Turkey
- Prev
- 1
- 2
- 3
- Next
News
No news found